Cleared Traditional

K961488 - ELECSYS T-UPTAKE ASSAY

K961488 is an FDA 510(k) clearance for ELECSYS T-UPTAKE ASSAY, manufactured by Boehringer Mannheim Corp.. The device is a Class 2 Chemistry device with product code KHQ cleared through the Traditional 510(k) pathway after a 55-day FDA review.

K961488 · Boehringer Mannheim Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1996
Decision
55d
Days
Class 2
Risk

K961488 is an FDA 510(k) clearance for the ELECSYS T-UPTAKE ASSAY. Classified as Radioassay, Triiodothyronine Uptake (product code KHQ), Class II - Special Controls.

Submitted by Boehringer Mannheim Corp. (Concord, US). The FDA issued a Cleared decision on June 12, 1996 after a review of 55 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1715 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Boehringer Mannheim Corp. devices

FDA 510(k) Submission Details - K961488

510(k) Number K961488 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 18, 1996
Decision Date June 12, 1996
Days to Decision 55 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
33d faster than avg
Panel avg: 88d · This submission: 55d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KHQ Device Classification - Class 2, Special Controls

Product Code KHQ Radioassay, Triiodothyronine Uptake
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1715
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - KHQ Radioassay, Triiodothyronine Uptake

All 58
Devices cleared under the same product code (KHQ) and FDA review panel - the closest regulatory comparables to K961488.
VITROS IMMUNODIAGNOSTICS PRODUCTS T3 UPTAKE REAGENT PACK (GEM.1025) AND T3 UPTAKE CALIBRATORS (GEM.C025)
K964308 · Johnson & Johnson Clinical Diagnostics, Inc. · Nov 1996
CEDIA T UPTAKE ASSAY
K954807 · Boehringer Mannheim Corp. · Dec 1995
T-UPTAKE EIA TEST
K951586 · Diagnostic Reagents, Inc. · May 1995
STRATUS(R) THYROID UPTAKE FLUOR ENZYME IMMUNOASSAY
K933414 · Baxter Diagnostics, Inc. · Nov 1994
AXSYM(TM) T-UPTAKE
K934312 · Abbott Laboratories · Jun 1994
VIDAS T UPTAKE
K935816 · Biomerieux Vitek, Inc. · Mar 1994